Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

647
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
647
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

154
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
154
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

316
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
316
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.4K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

725
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
725
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
  1. Home
  3. Methodological Quality And Clinical Recommendations Of Guidelines On The Management Of Dyslipidaemias For Cardiovascular Disease Risk Reduction: A Systematic Review And An Appraisal Through Agree Ii And Agree Rex Tools.
  1. Home
  3. Methodological Quality And Clinical Recommendations Of Guidelines On The Management Of Dyslipidaemias For Cardiovascular Disease Risk Reduction: A Systematic Review And An Appraisal Through Agree Ii And Agree Rex Tools.

Related Experiment Video

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for

Flávia Deffert1, Ana Paula Oliveira Vilela2, Alexandre de Fátima Cobre1

  • 1Pharmaceutical Sciences Postgraduate Program, Universidade Federal do Paraná, Av. Pref. Lothário Meissner, 632, Jardim Botânico, Curitiba, PR 80210-170, Brazil.

Family Practice
|June 4, 2024

View abstract on PubMed

Summary
This summary is machine-generated.
Keywords:
adultdyslipidemiashealth carehumanspractice guidelines as topic/standardsquality assurancequality of health care

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Experiment Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

This study found that many clinical practice guidelines (CPGs) for dyslipidemia management lack methodological rigor. Improved CPGs are needed to ensure effective lipid management and better cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Evidence-Based Medicine
  • Health Policy

Background:

  • Clinical practice guidelines (CPGs) are crucial for healthcare decisions, but low-quality guidelines can negatively impact patient outcomes, particularly in non-communicable diseases like cardiovascular disease.
  • Poor lipid management is a significant concern, highlighting the need for high-quality CPGs to guide effective dyslipidemia treatment.

Approach:

  • A systematic review was conducted to assess the quality of CPGs on dyslipidemia management.
  • Searches for CPGs on adult dyslipidemia pharmacological treatments were performed across PubMed, Scopus, and Trip databases.
  • The AGREE II and AGREE-REX tools were used to evaluate methodological quality and recommendation excellence, with qualitative synthesis of updated recommendations.

Key Points:

  • 66 guidelines from professional societies were analyzed, with high scores in Scope and Purpose and Clarity of Presentation.
  • A significant proportion of guidelines (46%) demonstrated poor methodological quality or documentation.
  • Implementability data for practical recommendations was scarce (38%), indicating a gap in practical application.

    • Conclusions:

    • There is a need for high-quality dyslipidemia CPGs, especially from outside North America and Europe, focusing on robust evidence synthesis and appraisal.
    • CPG developers must consider stakeholder values and adapt guidelines for individual populations and healthcare systems to ensure successful implementation.
    • Improved CPGs are essential for guiding primary care decisions and enhancing lipid management for better cardiovascular health.